Converge Technology Solutions Corp.
Converge Technology Solutions Corp. (CTSDF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Converge Technology Solutions Corp. (CTSDF), covering cash flow, earnings, and balance sheets.
Converge Technology Solutions Corp. (CTSDF) Income Statement & Financial Overview
Review Converge Technology Solutions Corp. CTSDF income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $680.78M | $630.69M | $651.85M | $628.77M |
Cost of Revenue | $502.15M | $472.43M | $497.77M | $477.71M |
Gross Profit | $178.63M | $158.26M | $154.08M | $151.06M |
Gross Profit Ratio | $0.26 | $0.25 | $0.24 | $0.24 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $135.22M | $131.80M | $137.08M | $136.66M |
Operating Expenses | $178.63M | $158.26M | $137.08M | $136.66M |
Total Costs & Expenses | $680.78M | $630.69M | $634.85M | $614.37M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $8.10M | $7.13M | $7.33M | $8.43M |
Depreciation & Amortization | $23.58M | $22.86M | $26.97M | $27.04M |
EBITDA | $10.47M | $23.27M | -$138.32M | $41.44M |
EBITDA Ratio | $0.02 | $0.04 | -$0.21 | $0.07 |
Operating Income | $0.00 | $0.00 | $16.99M | $14.39M |
Operating Income Ratio | $0.00 | $0.00 | $0.03 | $0.02 |
Other Income/Expenses (Net) | -$21.21M | -$6.72M | -$189.61M | -$14.37M |
Income Before Tax | -$21.21M | -$6.72M | -$172.62M | $28000.00 |
Income Before Tax Ratio | -$0.03 | -$0.01 | -$0.26 | $0.00 |
Income Tax Expense | -$12.03M | -$3.41M | -$7.66M | $3.57M |
Net Income | -$9.17M | -$3.31M | -$163.32M | -$1.91M |
Net Income Ratio | -$0.01 | -$0.005 | -$0.25 | -$0.003 |
EPS | -$0.05 | -$0.02 | -$0.82 | -$0.009 |
Diluted EPS | -$0.05 | -$0.02 | -$0.82 | -$0.009 |
Weighted Avg Shares Outstanding | $188.61M | $195.11M | $199.62M | $203.68M |
Weighted Avg Shares Outstanding (Diluted) | $188.61M | $195.11M | $199.62M | $203.68M |
The company's financials show resilient growth, with revenue advancing from $628.77M in Q1 2024 to $680.78M in Q4 2024. Gross profit remained healthy with margins at 26% in Q4 2024 compared to 24% in Q1 2024. Operating income hit $0.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $10.47M. Net income dropped to -$9.17M, while earnings per share reached -$0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan